Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Queensland Health
Federal Trade Commission
US Department of Justice
Daiichi Sankyo

Generated: February 18, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019818

« Back to Dashboard

NDA 019818 describes ADAGEN, which is a drug marketed by Sigma Tau and is included in one NDA. It is available from one supplier. Additional details are available on the ADAGEN profile page.

The generic ingredient in ADAGEN is pegademase bovine. One supplier is listed for this compound. Additional details are available on the pegademase bovine profile page.
Summary for 019818
Applicant:Sigma Tau
Ingredient:pegademase bovine
Therapeutic Class:Enzyme Replacements/Modifiers
Pharmacology for NDA: 019818
Ingredient-typeAdenosine Deaminase
Suppliers and Packaging for NDA: 019818
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ADAGEN pegademase bovine INJECTABLE;INJECTION 019818 NDA Leadiant Biosciences, Inc. 57665-001 N 57665-001-01

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength250 UNITS/ML
Approval Date:Mar 21, 1990TE:RLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.